GRI Bio Secures Nasdaq Compliance with $8M Offering, Approves Reverse Stock Split Amidst Delisting Concerns

summarizeSummary

GRI Bio, Inc. is taking aggressive measures to maintain its Nasdaq listing, which carries significant implications for shareholders. The $8.0 million public offering, while resolving the immediate threat of delisting due to insufficient stockholders' equity, represents an extremely high level of dilution relative to the company's current market capitalization. This suggests a critical need for capital and could severely impact existing shareholder value. Furthermore, the approval of a flexible reverse stock split indicates the company is likely preparing to address the Nasdaq minimum bid price requirement, another common delisting trigger for micro-cap companies. Investors should be aware of the substantial dilution and the ongoing challenges the company faces in maintaining its public listing.

check_boxKey Events

• Nasdaq Non-Compliance Addressed

  The company received a notice from Nasdaq for non-compliance with the minimum stockholders' equity requirement of $2.5 million.

• Completed $8.0 Million Public Offering

  GRI Bio completed a best efforts public offering on December 12, 2025, raising approximately $8.0 million in gross cash proceeds through the sale of common stock and warrants.

• Equity Compliance Restored

  As a result of the offering, the company believes its stockholders' equity now exceeds Nasdaq's $2.5 million minimum requirement, though Nasdaq will continue to monitor compliance.

• Reverse Stock Split Approved

  Shareholders approved an amendment to the company's Certificate of Incorporation to effect a reverse stock split at a ratio between one-for-two and one-for-thirty, with the Board having discretion on the exact ratio and implementation.

auto_awesomeAnalysis

GRI Bio, Inc. is taking aggressive measures to maintain its Nasdaq listing, which carries significant implications for shareholders. The $8.0 million public offering, while resolving the immediate threat of delisting due to insufficient stockholders' equity, represents an extremely high level of dilution relative to the company's current market capitalization. This suggests a critical need for capital and could severely impact existing shareholder value. Furthermore, the approval of a flexible reverse stock split indicates the company is likely preparing to address the Nasdaq minimum bid price requirement, another common delisting trigger for micro-cap companies. Investors should be aware of the substantial dilution and the ongoing challenges the company faces in maintaining its public listing.